Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-Blind, Randomized, Parallel Group, Vehicle-Controlled Study to Determine the Clinical Equivalence of a Generic Imiquimod Cream, 5% and Aldara™ Cream in Subjects With Actinic Keratosis
Conditions
Interventions
imiquimod
Aldara™
+1 more
Locations
20
United States
Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
Associates in Research, Inc.
Fresno, California, United States
Skin Surgery Medical Group, Inc.
San Diego, California, United States
Cherry Creek Research, Inc.
Denver, Colorado, United States
FXM Research Corp.
Miami, Florida, United States
MedaPhase, Inc.
Newnan, Georgia, United States
Start Date
May 1, 2008
Primary Completion Date
March 1, 2009
Completion Date
April 1, 2009
Last Updated
September 4, 2020
NCT06385340
NCT06321003
NCT06499415
NCT03906253
NCT05987553
NCT03066843
Lead Sponsor
Actavis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions